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Purpose: Clinical practice with people with intellectual disability relies heavily upon caregiver report. Crucially, the carer’s
perspective may depend upon his or her relationship to the patient. We investigated similarities and differences within and
between family and paid carers in their reports on the Glasgow Epilepsy Outcome Scale (GEOS), an instrument that quantifies
concerns about epilepsy in this population [Epilepsia 42 (2001) 1043].
Methods: GEOS forms were available on 186 patients (108 males; mean age 39 years) across 384 primary respondents (141
staff, 83 family, 160 clinicians) and independently completed secondary respondents (67 staff, 36 family). Data were analysed
to consider levels of concern as rated bv staff carers, family members and clinicians, and also to consider inter-rater agreement
on the concerns raised.
Results: There were significant differences in the magnitude of concern on each sub-scale [concerns about seizures, treatment,
caring and social impact; range of F(2, 171) = 9.5–64.7; all P < 0.0001]. Post hoc testing revealed that family members scored
all sub-scales more highly than staff carers or clinicians, and that staff carers scored more highly than clinicians on all but one
sub-scale. Inter-rater agreement between family members was considerably higher (range of r = 0.69–0.91) than between staff
carers (r = 0.30–0.47) across the GEOS sub-scales. Association between staff and family ratings was also modest (r ≤ 0.39).
Conclusions: It is preferable for the same staff member to complete each administration of the GEOS because of inter-staff vari-
ability in reporting of concerns. Families provide a consistent, but more extreme, picture and clinicians generally underestimate
the concerns of direct caregivers. However, content of concerns varies relatively little across respondents.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Many people with intellectual disability (mental retar-
dation) have epilepsy. Prevalence rates vary, depend-
ing upon the source of the sample (e.g. community/
health facility), and the severity of neurological im-
pairment, but around 25% appears to be a reasonable
and conservative figure2–4. Thus, people with intel-
lectual disability are 20–30 times more likely to have
epilepsy than the general population5, 6. It follows that
understanding the needs of this group is particularly
important within any major epilepsy service.
Working clinically with people with intellectual
disability, however, can be particularly challenging.
Seizures may present in atypical ways, response to
antiepileptic drugs (AEDs) may be less than optimal,
and less good than in the wider epilepsy popula-
tion, there are often co-morbid health, mental health
or sensory difficulties, and effective communication
usually has to be through a caregiver7–10. Although
1059–1311/02/$30.00 © 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
196 C. A. Espie et al.
there is increasing recognition of such factors in the
literature10–12, in epilepsy service documents13, 14,
and in disability-specific guidelines8, validated in-
struments are required to provide a metric of severity
of problem and treatment-related change12, 16. This
is not only a matter of having accurate data on fre-
quency and type of seizures, but also a means of
appraising epilepsy-related concerns, and appraising
the intrusiveness of both the seizures themselves and
the concerns about them, upon day to day life15.
In recent years we have been following a pro-
gramme of research committed to the development of
such measures (the Glasgow Epilepsy Outcome Scales
(GEOSs)1, 17, 18). Our approach has been to start with
qualitative methodology, to identify the key issues
for those involved with the person with epilepsy, and
to progress through quantitative, scale development
methods, to derive measures which have robust psy-
chometric properties. We believe this approach is
appropriate because the clinical assessment of people
with intellectual disability and epilepsy must be able
to take into account the background, experience and
care perspective of the person expressing the patient’s
need at the outpatient appointment. After all, does a
parent observe seizure events, and attach significance
to them in the same way as a member of residential
or day care or respite staff? Do different people’s
perspectives on the effects or side-effects of AEDs,
or on improvement or deterioration in quality of life
necessarily concur? Does the patient experience the
same concerns about having epilepsy as members of
his/her family? And what do clinicians by comparison
feel are the major concerns?
Those working in this field recognise the impor-
tance of a reliable witness and informant, and would
readily agree with the recommendation that the same
carer should accompany the person with epilepsy and
intellectual disability to each clinic appointment8.
However, there are few if any data on this, and this
principle may need to be reinforced by evidence in
order to influence care practice. Besides, the differing
perspectives that people may have require exploration
because many people with intellectual disability have
multiple carers, who come from different backgrounds
and who form different types of attachment. Perhaps
we should not expect unanimity of opinion or con-
cern, but rather be equipped accurately to appraise a
range of expressed needs.
METHODS
Our aim in this study was to investigate possible dif-
ferences between the proxy reports of those directly
involved in the care and management of people with
epilepsy and intellectual disability. More specifically,
we wanted to compare family carer reports with staff
carer reports, to consider the association between re-
ports provided by different family members and dif-
ferent members of care staff, and to compare clinician
reports with both family and staff reports. Develop-
ment work on the GEOS1 provided the opportunity to
study these important clinical matters.
Sample
A database of potential subjects was compiled com-
prising information on 685 people with epilepsy and
intellectual disability in Glasgow and Edinburgh. In-
clusion criteria were: (a) adults in the age range 18–60
years, (b) with at least mild intellectual disability ac-
cording to World Health Organisation definitions (in-
cluding previous attendance at ‘special school’), (c)
epilepsy confirmed by clinical history and diagnosis,
(d) having a minimum of one seizure per month on
average and (e) a carer (family and/or staff) who had
participated in care decisions for at least the preceding
3 months. Exclusion criteria were deteriorating health,
particularly neurological disorder, and/or established
non-epileptic seizure disorder as the principal clini-
cal problem. The database was used to select 250 us-
ing random number sequences generated by SPSS. Of
these, seven carers refused participation and attempts
to make contact with 54 were unsuccessful. There-
fore, agreement to participate was reached for 189,
however, three were excluded due to age (n = 2) and
non-epileptic seizures (n = 1).
Measures
Our primary measure was the 90-item version of
the Glasgow Epilepsy Outcome Scale (GEOS-90),
an instrument specifically validated to assess carer
concerns about epilepsy in people with intellec-
tual disability1. The GEOS-90 yields four sub-scale
scores; ‘concerns about seizures’ (30 items), ‘con-
cerns about treatment’ (26 items), ‘concerns about
caring’ (14 items) and ‘concerns about social impact’
(20 items). Respondents are asked to focus upon
the epilepsy-related needs of the person they care
for, over the preceding 3 months, and to rate each
item using a 5-point Likert scale comprising—0
‘never a concern/not applicable’, 1 ‘only occasion-
ally a concern’, 2 ‘fairly often a concern’, 3 ‘often a
concern’ and 4 ‘very often a concern’. The GEOS-90
and its sub-scales have strong internal consistency
(α ≥ 0.94) and reasonable discriminant validity1.
GEOS-90 forms were sent and returned by conven-
tional mail. We also calculated GEOS-35 scores (the
35-item short-form version of the scale1), and made
similar comparisons using these.
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A range of other measures was completed as part of
a structured interview and history taken from carers.
The Vineland Adaptive Behaviour Scales (V-ABS)19
provided an estimate of patient functioning. Carer
coping was assessed using the Caregiver Strain Index
(CSI)20 and the Hospital Anxiety and Depression
Scale (HADS)21. We adapted the CSI, originally de-
veloped for use with carers of people after stroke,
and found that it had acceptable internal consistency
(α = 0.80)22. Carer knowledge of epilepsy was mea-
sured by Epilepsy Knowledge Profile (EKP)23.
RESULTS
Descriptive information
From the 186 retained participants (74%), 132 family
carers and 173 staff carers were identified to complete
the GEOS-90, which was returned completed by 83
(63%) and 141 (82%) carers, respectively. A second
family member was identified for 36 patients, and a
second paid carer for 67 patients. These carers also
completed and returned the GEOS-90, independently
of the principal carer. Clinicians involved in epilepsy
management (mainly medical practitioners, but also
some epilepsy nurse specialists and neuropsycholo-
gists) were identified for 172 of the 186 individuals,
and, of these, 160 returned completed GEOS-90 forms
(93%).
Care information
Nearly half of the 186 patients lived at home with rel-
atives (n = 76, 41%) and a similar number lived in
the community with staff carers (n = 84, 45%). The
remaining 26 (14%) lived in an institutional setting.
One hundred and eighteen (63%) lived in the Glasgow
area, and 68 (37%) in the Edinburgh area, consistent
with population estimates of people with intellectual
disability in these districts. As anticipated, there were
more males (n = 108, 58%) than females (n = 78,
42%). Mean age was 39 years in staffed care, sig-
nificantly older than the mean of 31 years in clients
who lived at home with family (mean diff. 7.69 years,
CI 95% 4.45–10.9). Level of mental retardation was
assessed from clinical sources. Three-quarters (n =
139, 75%) had at least moderate mental retardation, of
whom 27 (15%) were profoundly retarded. Functional
assessment on the V-ABS skills revealed that all had
a deficit in adaptive daily living skills with 14 (8%)
exhibiting borderline, 20 (11%) mild, 8 (4%) moder-
ate, 15 (8%) severe and 128 (69%) profound deficit.
No significant difference was found between those liv-
ing at home and those ‘in care’. One-quarter (n = 47,
25%) of the sample was non-ambulant, 27 (15%) had
hearing impairment, 62 (33%) visual impairment and
55 (30%) had no speech.
The mean age of family carers was 57 years com-
pared to 37 years in staff carers (mean diff. 19.4 years,
CI 95% 16.0–22.8). Correspondingly, family carers
had also known and cared for the person with epilepsy
for significantly longer, a mean of 28.7 years compared
to 5.8 years in staff carers. All carers, however, had
cared for the individual for at least 3 months. Epilepsy
knowledge did not differ significantly between staff
and family carers. On the EKP medical sub-scale the
overall mean score was 27 (79% correct) and on the so-
cial sub-scale it was 15.8 (71% correct). These scores
are consistent with those reported in a recent study17.
Levels of caregiver strain were assessed only in family
carers because staff carer scores could not be linked
to a specific person. Strain was found to be above av-
erage, with 43 carers (53%) scoring above the norm
for ‘higher than average stress’ on the CSI. Using the
recognised cut-off score of 11 on the HADS, 24 fam-
ily carers (34%) reached ‘caseness’ on anxiety and 8
carers (11%) had significant depressive symptoms.
Clinical information
Epilepsy was most often managed by an epilepsy
specialist/consultant neurologist (68%) and/or the
client’s general medical practitioner (49%). In many
cases (n = 78, 42%) both the neurologist and GP
were involved. In 14 cases (1%), epilepsy was not
currently managed by any clinician. Polypharmacy
was common: 62 patients (33%) were prescribed two
AEDs, 58 (31%) three AEDs and 16 (9%) four or
more AEDs. Fifty patients were on AED monotherapy
(27%). Mean age at onset of epilepsy was 4.5 years,
ranging from birth to 38 years. Seizure frequency
varied enormously, ranging to over 2000 seizures per
year. Forty clients (22%) had seizures at least daily,
63 (35%) had seizures at least weekly, 56 (31%) had
at least one seizure per month and 22 (12%) less
frequently (n = 181, five missing cases). Detailed de-
scriptions of seizure presentations were obtained from
the principal carer, including seizure patterns, nature
of onset, duration, movements, incontinence, loss of
consciousness/responsiveness, injuries and post-ictal
behaviours. These descriptions were rated blind by an
experienced epileptologist to obtain an assessment of
likely seizure types (available n = 182). The majority
of patients had more than one seizure type (52%).
Most common were tonic–clonic (61%) and complex
partial seizures (44%) with myoclonic and absence
seizures each at 10%. Forty-four patients (24%) had
some seizures coded as unclassifiable on the basis of
available descriptions.
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Table 1: Comparison of mean scores (SD) on the GEOSs as rated by clinicians (n = 160), staff carers (n = 141) and family
members (n = 83).
F df P Clinicians (1) Staff (2) Family (3) Post hoc
GEOS-90
Concerns about seizures 44.9 2, 381 <0.0001 24.1 (23.9) 36.7 (23.3) 56.1 (29.7) 3 > 2 > 1
Concerns about treatment 39.9 2, 381 <0.0001 17.8 (19.7) 24.2 (19.2) 40.7 (25.7) 3 > 2 > 1
Concerns about caring 22.7 2, 381 <0.0001 9.52 (11.5) 11.4 (9.38) 21.1 (15.4) 3 > 2 > 1
Concerns about social impact 26.2 2, 381 <0.0001 13.3 (16.5) 21.1 (18.5) 32.1 (24.7) 3 > 2 = 1
GEOS-90 total 42.4 2, 381 <0.0001 64.7 (66.1) 93.5 (60.0) 150.2 (85.2) 3 > 2 > 1
GEOS-35
Concerns about seizures 46.6 2, 381 <0.0001 8.32 (8.51) 12.8 (8.25) 20.1 (10.9) 3 > 2 > 1
Concerns about treatment 34.1 2, 381 <0.0001 6.49 (7.08) 8.94 (7.38) 15.2 (9.81) 3 > 2 > 1
Concerns about caring 31.9 2, 381 <0.0001 5.41 (6.60) 6.21 (5.37) 12.5 (9.23) 3 > 2 > 1
Concerns about social impact 23.8 2, 381 <0.0001 5.25 (6.61) 8.50 (7.68) 12.5 (10.1) 3 > 2 = 1
GEOS-35 total 43.7 2, 381 <0.0001 25.4 (26.2) 36.5 (24.1) 60.4 (34.8) 3 > 2 > 1
Univariate analyses are one-way ANOVAs with post hoc testing (Bonferroni; P < 0.05).
Between-group comparisons on the GEOS
Comparative data on the GEOS-90 and GEOS-35 to-
tal scale and sub-scale scores are presented in Table 1.
As can be seen, family carers consistently expressed
the greatest levels of concern about seizures, their
treatment, about caring for the person with epilepsy
and about its social impact. Their scores were typi-
cally 0.5–1.0 SD higher than staff carer scores, and
1.0–1.5 SD higher than clinician scores. Staff ratings
were generally intermediate, and with the exception of
concerns about social impact, were also significantly
higher than clinician ratings on both the GEOS-90 and
GEOS-35. This ordering of results across groups is
illustrated in Fig. 1, where GEOS-90 scores are pre-
sented as a percentage of the total possible sub-scale
scores. Because each sub-scale comprises a differ-
ent number of items, the conversion to percentages
in Fig. 1 also permits comparison across sub-scales.
It is clear that, despite highly significant inter-rater
differences in terms of magnitude of concern, there
appears to be a similar pattern across the sub-scale
Fig. 1: Comparison of clinician (n = 160), staff carer (n = 141) and family carer (n = 83) scores on GEOS-90 sub-scales,
expressed as a percentage of total sub-scale score.
domains, particularly between the two carer groups.
Family, staff carer and clinicians all rated concerns
about seizures as marginally greater than the other
sub-scales.
The above analyses make best use of our avail-
able data because they are on sizeable sub-groups
(i.e. clinicians = 160, staff = 141, family = 83),
thereby also serving the purpose of providing some
normative GEOS data for these raters. However, we
also analysed our data to look at score profiles on a
within-subject basis, i.e. the clinician, staff carer and
family carer scores for each individual. This is a much
smaller dataset because not all subjects had both types
of carer and also a clinician from whom ratings were
available. We examined full data (three sets of GEOS
scores) on 58 patients and found that for all sub-scales
and total scores, for both the GEOS-90 and GEOS-35,
one-way ANOVAs remained highly significant [range
of F(2, 171) = 11.8–27.5; all P < 0.0001]. Post
hoc testing (Bonferroni; P < 0.05) also confirmed
that family carers scored significantly higher than ei-
ther staff carers or clinicians on all sub-scales, and
Perspectives on epilepsy 199
Table 2: Rank order of the top 10 items from the GEOS-35 as rated by clinicians, staff carers and family carers.
Rank Clinicians Staff Family
1 It is difficult to find the right
combination of drugs for epilepsy (Tx)
After a seizure the person is confused
and disoriented (Sz)
It is difficult to find the right
combination of drugs for epilepsy (Tx)
2 Falling down during a seizure (Sz) Falling down during a seizure (Sz) Falling down during a seizure (Sz)
3 Carers worry about the person having a
seizure when out (Care)
There are concerns about the person
choking during a seizure (Sz)
There are concerns about the person
choking during a seizure (Sz)
4 After a seizure the person is confused
and disoriented (Sz)
Because of epilepsy the person has less
independence (Soc)
After a seizure the person is confused
and disoriented (Sz)
5 There are concerns about the person
choking during a seizure (Sz)
It is difficult to find the right
combination of drugs for epilepsy (Tx)
It is difficult to differentiate the effects
of learning disability from drug effects
(Tx)
6 It is difficult to differentiate the effects
of learning disability from drug effects
(Tx)
The person has one seizure after
another (Sz)
There are concerns that it is not
possible to stop the seizures (Sz)
7 There are concerns that it is not
possible to stop the seizures (Sz)
It is difficult to differentiate the effects
of learning disability from drug effects
(Tx)
After a seizure there are behaviour
problems (Sz)
8 Because of epilepsy the person has less
independence (Soc)
Because of epilepsy people
underestimate the person’s ability (Soc)
Carers worry about the person having a
seizure when out (Care)
9 Because of epilepsy people
underestimate the person’s ability (Soc)
After a seizure there are behaviour
problems (Sz)
Because of epilepsy the person has less
independence (Soc)
10 The person has one seizure after
another (Sz)
Carers worry about the person having a
seizure when out (Care)
Because of epilepsy carers lose their
own independence (Care)
Items are from GEOS sub-scales as indicated (Sz = concerns about seizure; Tx = concerns about treatment; Care = concerns about
caring; Soc = concerns about social impact).
that staff scored significantly higher than clinicians
on concerns about seizures, treatment, and social im-
pact on the GEOS-90, and on concerns about seizures
on the GEOS-35. Total scores on both the GEOS-90
and GEOS-35 demonstrated significantly higher rat-
ings for family over both staff and clinicians, and for
staff carers over clinicians. Thus, our secondary anal-
ysis broadly confirmed the larger sample of data pre-
sented in Table 1 and Fig. 1.
Highest rated concerns on the GEOS-35
across groups
Table 2 presents a rank order of the top 10 items in
terms of mean score, for each of the sub-groups. This
illustrates, similarly to Fig. 1, that there was consid-
erable communality of concern amongst family, staff
carers and clinicians. For each of the three rater groups
the same seven items were independently included;
Table 3: Inter-rater agreement rates for the GEOS scales as measured by the intra-class or product-moment correlation
coefficient.
Staffa Familya Staff × familyb Staffa Familya Staff × familyb
(GEOS-90) (GEOS-90) (GEOS-90) (GEOS-35) (GEOS-35) (GEOS-35)
Concerns about seizures 0.380** 0.851*** 0.281** 0.354** 0.842*** 0.393**
Concerns about treatment 0.353** 0.830*** 0.237* 0.308** 0.856*** 0.241*
Concerns about caring 0.323** 0.883*** 0.199* 0.301** 0.910*** 0.217*
Concerns about social impact 0.469** 0.685*** 0.293** 0.418** 0.673*** 0.212*
Total concerns 0.445** 0.834*** 0.261** 0.408** 0.848*** 0.274**
For staff comparisons n = 67 pairs of scores; for family n = 36 pairs of scores and for staff× family n = 40 pairs.
a Intra-class correlation coefficient. b Product–moment correlation coefficient.
* P < 0.01; ** P < 0.001; *** P < 0.0001.
and the only item not reaching the top 10 for more than
one group was ranked tenth. (‘Because of epilepsy car-
ers lose their own independence’—family carers list-
ing.) Furthermore, each group included seven items
reflecting concerns about seizures or their treatment,
and three reflecting psychosocial concerns. Clinicians
and family members had the same two items in the
first two ranks. The overwhelming conclusion from
this analysis is that it is primarily the magnitude of ex-
pressed concern that varies between these respondent
groups rather than the nature or content of the scales
per se.
Inter-rater agreement on the GEOS
Intra-class and product–moment correlation coeffi-
cients were calculated for within-group and between-
group measures of association, respectively (Table 3).
Inter-rater agreement between pairs of family
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members was high both for the GEOS-90 (range
of r = 0.69–0.88) and GEOS-35 (r = 0.67–0.91).
Agreement on three of the sub-scales of the GEOS-90
explained around two thirds of variance (r ≥ 0.83)
and was at a similar level for the same three GEOS-35
sub-scales. Scores on the fourth sub-scale in each
case, concerns about social impact, correlated 0.69
and 0.67, respectively (around 45% shared variance).
Agreement between staff carers was more modest
(r = 0.32–0.47 for GEOS-90, r = 0.31–0.42 for
GEOS-35), typically representing around 15% of
shared variance, although here social impact demon-
strated inter-correlation at the higher end of the range.
Association between staff and family ratings was
also modest (r ≤ 0.29 for GEOS-90, r ≤ 0.39 for
GEOS-35).
DISCUSSION
This study provides preliminary norms for the 90- and
35-item versions of the GEOS1 on a modest sample
(n = 186). These patients were drawn at random from
a large clinical database of 685 people with epilepsy
and intellectual disability, adding to the potential gen-
eralisability of the data. Nevertheless, we would en-
courage caution in interpreting our data for normative
purposes until further cohorts are available from other
geographical locations.
Our primary aim, however, was not to establish
norms, but to compare profiles of epilepsy-related
Table 4: Recommendations concerning the use of the GEOS scales in clinical practice with adults with epilepsy and
intellectual disability.
1 The GEOS should be completed by a carer who is familiar with the person with epilepsy and intellectual disability; in
particular being familiar with how epilepsy presents, its impact and its management
2 Ideally, the carer should have had direct involvement with the person for years. This will be so for family carers. In the case
of care staff, lengthy direct involvement is also preferable, with 3 months at ‘keyworker’ level as the recommended minimum
3 Where both family members and staff carers are directly involved with the person’s care it is preferable to have separate
GEOS assessments from each source, each completed by the most appropriate person
4 When repeat assessment is planned (e.g. to appraise change in concerns about epilepsy over time), the same person(s)
should be asked to complete the re-assessment
5 If it is not possible for the same family carer to do so, another family member may substitute providing she/he has also
been directly involved (consistent with points 1 and 2 discussed earlier). This is because, in most cases, family members
have similar concerns about epilepsy
6 If the same staff carer is unable to complete re-assessment, appraisal should be made of the extent to which the
individual’s epilepsy needs have been discussed within the care setting. The aim is to establish whether or not a shared
understanding of the person’s epilepsy and its impact is part of the person’s overall plan of care. This is because it cannot
otherwise be assumed that staff will have a similar perspective on concerns about epilepsy
7 If these conditions are satisfied, another staff member may substitute providing she/he has also been directly involved at
‘keyworker’ level (consistent with points 1 and 2 discussed earlier). If not, assessment by another member of staff may be
best understood as representing a further baseline
8 Clinicians may also complete the scale, with the GEOS-35 being the most practicable. This may help the clinician toward
greater appreciation of the potential impact of epilepsy
9 GEOS sub-scale profiles obtained from family, carer, or clinician informants may be compared with preliminary norms
(Table 1); and profiles across more than one informant type may be compared with Fig. 1 which illustrates the differences
in emphasis which may be expected
10 Information from the GEOS is intended as complementary to other means of appraising epilepsy-related needs. This
appraisal should always take individual circumstances into account
concerns, from the perspectives of a family member,
a paid member of care staff and a clinician. Our find-
ings of significant differences between these perspec-
tives may be largely unsurprising to the experienced
practitioner, but this has not in fact been reported pre-
viously in a formal study. We suggest that this demon-
stration of variability, primarily in the magnitude of
emphases, accurately reflects valid differences in the
priorities of informants, all of whom are in some
respect ‘stakeholders’ in the care process. There are
important implications for use of the GOES with this
population, and some of these are listed in Table 4.
Family members have long histories of care in-
volvement, have strong emotional attachments and
traditionally have taken on the advocating role on
behalf of their relative. We do not find it surpris-
ing, therefore, that their ratings on the GEOS were
consistently the highest in all domains amongst the
groups we compared. Indeed, the degree of concern
expressed about epilepsy, bearing in mind that aver-
age time since diagnosis of epilepsy was some 25–30
years, pointedly illustrates the persisting importance
of epilepsy in the life of the family. Our results also
demonstrate that family members share a common
perception of the needs of the person with epilepsy
and intellectual disability. In our sample most of these
pairings were mother/father or mother/sibling, and
we obtained correlation coefficients of r = 0.83 and
r = 0.85 for the GEOS-90 and GEOS-35. This level
of between-subject, inter-rater agreement is, in fact,
similar to what we obtained for within-subject, test
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re-test purposes on the pilot version of our scale (r =
0.86)17. This consistency, therefore, suggests that
clinicians can be reasonably sure that they will hear
a similar version of events from different members of
the same family. In other words, there is likely to be
a shared family perspective on the needs of and con-
cerns about the person with epilepsy and intellectual
disability.
The majority of the care staff who participated
in our study was residential staff, principally the
‘keyworkers’ of our patients. These were all individ-
uals who had known the person with epilepsy for a
minimum of 3 months, and on average for almost 6
years. Although these carers also reported substantial
concerns about epilepsy, their ratings for concerns
about seizures, treatment, caring and social impact
were considerably but fairly consistently lower (by
0.5–1.0 SD) than those provided by family members.
Nevertheless, staff carer ratings were higher than
those provided by clinicians for three of the four
sub-scales (excepting social impact). Thus, we con-
sider the GEOS staff score profile as intermediate in
magnitude between family and clinician score profiles
(Fig. 1). Again, it is consistent with clinical expe-
rience that paid carers do not report concern about
seizures in quite the same way as family. They tend
to have less anxiety about events, perhaps because of
the different nature of their relationship to the patient,
the differing care history, and their primarily practical
rather than emotional involvement.
These results should not be taken to mean that paid
carers are in some respect less caring, or that families
are more caring. This would be a naı¨ve and inappropri-
ate interpretation of our data. Rather, we would argue
that it is inevitable that staff carers and family have a
different perspective; because they approach the care
situation from a different angle. We believe that both
perspectives are valid, but that they are not wholly in-
terchangeable (Table 4). The correlation between fam-
ily and staff carers was found to be significant but
low (r = 0.20–0.39, depending upon sub-scale). Sim-
ilarly, there appears to be less of a shared perspective
amongst staff care groups because inter-rater correla-
tion coefficients here ranged from r = 0.30 to 0.47.
This latter finding reinforces the importance of the
same member of staff accompanying the patient to
clinic appointments8, and of the same person when-
ever possible completing the GEOS (Table 4). Irre-
spective of this, however, we would suggest that such
a level of agreement is unacceptably low. We recom-
mend, therefore, that epilepsy needs should be made
more central to the overall care management plan for
the person with epilepsy and intellectual disability
(Table 4), and that organisations providing care should
ensure that staff involved develop a common under-
standing based upon shared concerns and priorities.
Perhaps it should be part of the ‘keyworker’ role to
oversee the shared epilepsy care plan within the care
setting. It should be noted that our study does not per-
mit comparison across different care settings (e.g. res-
idential, daycare, respite) and this might provide the
focus for a further study.
Our data should not be taken to suggest a lack of
concern amongst clinicians. Undeniably, practitioners
completing the GEOS scored uniformly lower than
family or staff carers, but their ‘clinical’ perspective
may inevitably fail to capture the implications, in-
trusiveness and ‘meaning’ of epilepsy to those more
intimately involved. Nevertheless, there was marked
similarity in the principal concerns raised by our
respondents, regardless of their type of involvement
(Table 2). The clinicians had three psychosocial items
in their top 10 rank order, as did the family mem-
bers and staff carers. Indeed, the highest ranking (at
number 3) of a psychosocial item was found in the
clinician data, suggesting at least that clinicians are
aware of carer anxieties. Furthermore, clinicians and
family members had the same items in ranks 1, 2
and 4. We are not particularly recommending the
GEOS as a clinician-completed instrument in rou-
tine practice. For research purposes this additional
comparison was of interest to us, and it may be in
future studies. Nevertheless, some clinicians may
find it practicable to complete the short-form ver-
sion (GEOS-35), and it would be valuable to have
more data for normative comparison of clinician
scores.
We hope that the suggestions concerning use of the
GEOS (Table 4) are justifiable on the basis of our re-
sults, and that they are also helpful to practitioners. We
recognise that the client perspective is missing from
this study, but we have been involved in a parallel
study directly with people with intellectual disability,
and this forms the basis of a separate report18. Much
work is still required in the field of epilepsy and intel-
lectual disability and we especially hope that our stud-
ies may prompt investigations of the GEOS in other
geographical locations. There may also be benefits of
applying our ‘care perspective’ methodology to other
sub-populations of people with epilepsy. For exam-
ple, we might reasonably expect different, but equally
valid views, from parents, teachers and children in re-
lation to epilepsy in childhood or teenage years; or
from family carers, paid carers and older people with
epilepsy.
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